DermTech, Inc.: Diferență între versiuni
The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei DermTech, Inc. listata cu simbolul US.DMTK ==Descriere companie== DermTech, Inc. (https://dermtech.com/) is a molecular diagnostics company. The Company is focused on developing and marketing non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases and aging-related conditions. It provides Pigmented Lesion Assay (PLA), which is a gene expression test that enables earl...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
DermTech, Inc. (https://dermtech.com/) is a molecular diagnostics company. The Company is focused on developing and marketing non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases and aging-related conditions. It provides Pigmented Lesion Assay (PLA), which is a gene expression test that enables early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The Company offers Nevome test, which is an adjunctive reflex test for the PLA and is used with histopathology to identify additional risk factors for melanoma and confirm the diagnosis. Its Adhesive Skin Sample Collection Kit offers properties of the adhesive, the collection of informative cellular material for its PLA. The Company’s Telemedicine Option for the PLA is the provision of health-related services and information through electronic information and telecommunication technologies. | DermTech, Inc. (https://dermtech.com/) is a molecular diagnostics company. The Company is focused on developing and marketing non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases and aging-related conditions. It provides Pigmented Lesion Assay (PLA), which is a gene expression [[test]] that enables early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The Company offers Nevome test, which is an adjunctive reflex test for the PLA and is used with histopathology to identify additional risk factors for melanoma and confirm the diagnosis. Its Adhesive Skin Sample Collection Kit offers properties of the adhesive, the collection of informative cellular material for its PLA. The Company’s Telemedicine Option for the PLA is the provision of health-related services and information through electronic information and telecommunication technologies. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||